Sign In
Buy IRIX
$1.18
+0 (+0%)
At Close: Jun 23, 2026
IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript
06:03pm, Thursday, 27'th Mar 2025
IRIDEX Corporation (NASDAQ:IRIX ) Q4 2024 Earnings Conference Call March 27, 2025 5:00 PM ET Company Participants Trip Taylor - Investor Relations Department Patrick Mercer - Chief Executive Officer R
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results
04:05pm, Thursday, 27'th Mar 2025
MOUNTAIN VIEW, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and p
Iridex Announces Strategic Investment in the Company
09:15am, Wednesday, 19'th Mar 2025
MOUNTAIN VIEW, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for
Iridex Comments on Recent Stock Price Volatility
07:00am, Friday, 14'th Mar 2025
MOUNTAIN VIEW, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
05:00pm, Thursday, 13'th Mar 2025
MOUNTAIN VIEW, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for
MOUNTAIN VIEW, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for t
Iridex Comments on Changing Glaucoma Reimbursement Landscape
08:14am, Tuesday, 19'th Nov 2024
MOUNTAIN VIEW, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pro
IRIDEX Corporation (IRIX) Q3 2024 Earnings Call Transcript
03:53pm, Saturday, 16'th Nov 2024
IRIDEX Corporation (NASDAQ:IRIX ) Q3 2024 Earnings Call Transcript November 12, 2024 5:00 PM ET Company Participants Scott Shuda - Executive Chairman Patrick Mercer - CEO Fuad Ahmad - Interim CFO Oper
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024
04:05pm, Monday, 04'th Nov 2024
MOUNTAIN VIEW, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pr
Iridex Appoints Patrick Mercer as Chief Executive Officer
04:05pm, Thursday, 03'rd Oct 2024
MOUNTAIN VIEW, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and pr
Iridex Frustrates, But Expect A Transaction By Year-End
11:16am, Monday, 26'th Aug 2024
IRIDEX has faced delays in selling its assets as part of a strategic review initiated a year ago, causing frustration among shareholders. Despite setbacks, the company remains committed to selling all
IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript
04:23pm, Saturday, 10'th Aug 2024
IRIDEX Corporation (NASDAQ:IRIX ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Philip Taylor – Investor Relations David Bruce – Chief Executive Officer Fuad Ahma
Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates
07:16pm, Thursday, 08'th Aug 2024
Iridex (IRIX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.17 per share a year ago.
IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript
03:27pm, Friday, 17'th May 2024
IRIDEX Corporation (NASDAQ:IRIX ) Q1 2024 Earnings Conference Call May 14, 2024 5:00 PM ET Company Participants Trip Taylor - Investor Relations David Bruce - Chief Executive Officer Fuad Ahmad - Inte
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates
07:01pm, Tuesday, 14'th May 2024
Iridex (IRIX) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.13 per share a year ago.
